Data collection for Medicare Beneficiaries Receiving FDG Positron Emission Tomography (PET) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and All Other Cancers
ICR 200811-0938-006
OMB: 0938-0968
Federal Form Document
⚠️ Notice: This information collection may be outdated. More recent filings for OMB 0938-0968 can be found here:
Data collection for Medicare
Beneficiaries Receiving FDG Positron Emission Tomography (PET) for
Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and All
Other Cancers
Extension without change of a currently approved collection
To qualify for payment, providers must
prescribe FDG PETs for beneficiaries with a set of clinical
criteria specific to each cancer type and stage. CMS is requiring
stakeholders including specialty societies, industry, health plans
and hospital associations to create systematic clinical data bases
or registries to be reimbursed for FDG PETs for beneficiaries. Data
elements collected electronically on the associated instrument will
be transmitted to CMS for evaluation of the short and long term
benefits of FDG PETs to beneficiaries and for use in future
clinical decision making.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.